MedPath

Candesartan may prevent aneurysmal changes in the residual native aorta after thoracic aortic aneurysm surgery

Not Applicable
Conditions
Thoracic aortic aneurysm
Registration Number
JPRN-UMIN000000756
Lead Sponsor
Graduate School of Medicine, Tohoku University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
150
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with contraindication for Candesartan Patients with allergic reaction to Candesartan Pregnant or potentially pregnant Patients who did not consent to the study Patients under 20 years of age Others who are not suitable to the enrollment from the physician's point of view

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in the aortic diameter
Secondary Outcome Measures
NameTimeMethod
Pulse wave velocity
© Copyright 2025. All Rights Reserved by MedPath